Xing, Xiaofang <br/><br/>
PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway.  [electronic resource] 

 -  Anti-cancer drugs  Nov 2014 
 - 1129-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0000000000000148  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood supply<br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Female<br/>Human Umbilical Vein Endothelial Cells--physiology<br/>Humans<br/>Indoles--pharmacology<br/>Male<br/>Mechanistic Target of Rapamycin Complex 1<br/>Mechanistic Target of Rapamycin Complex 2<br/>Middle Aged<br/>Multiprotein Complexes--metabolism<br/>Neoplasm Invasiveness--pathology<br/>Neoplasm Metastasis<br/>Neovascularization, Pathologic--metabolism<br/>Oncogene Protein v-akt--metabolism<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation<br/>Purines--pharmacology<br/>Ribosomal Protein S6 Kinases, 70-kDa--metabolism<br/>Signal Transduction<br/>Stomach Neoplasms--blood supply<br/>TOR Serine-Threonine Kinases--metabolism